Earnings Call · Q3 FY2025·2025-11-07

Q3 25EPS -13.79%·Rev n/aQ2 25EPS -56.00%·Rev n/aQ1 25EPS -59.09%·Rev n/aQ4 24EPS -100.00%*·Rev n/a⚠ consensus missing

Coherus Oncology, Inc. CHRS

Unknown Executive — Executive

Dennis Lanfear — Chief Executive Officer

Theresa Lavallee — Chief Scientific Officer

Rosh Dias — Chief Medical Officer

Sameer Goregaoker — Commercial Leader

Bryan McMichael — Chief Financial Officer

−10.1%1d on move date−10.2% vs SPY3d−9.4%5d−15.4%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CHRS calls or request research access.

More CHRS calls Browse calls Request research access